India Coronavirus Actions: Stock Checks, Kaletra Gx Readiness And Bulk Drugs

A string of actions to ensure medicines security and prioritize bulk drug project clearances are underway in India as the country enters a critical phase in its efforts to contain coronavirus cases.

India
India Takes Host Of Measures To Tackle Coronavirus-Related Supply Issues • Source: Shutterstock

The Indian government is keeping a hawk eye on medicines availability and pharma’s production readiness, including for the HIV combination lopinavir and ritonavir, as the country readies to tackle the threat of potential community transmission of the coronavirus infection.

As of 9.15am on 17 March, India had reported 125 confirmed COVID-19 disease cases, including foreign nationals, and two deaths...

Scrip Podcast

Keep up with the top pharma business news of the week. On the go.

Scrip brings you a weekly bulletin of top picks.

More from COVID-19

More from Scrip